編委:(1) The Scientific World Journal; (2) World Journal of Anesthesiology; (3) Edorium Journal of Anatomy and Embryology;(4)解剖學雜志;(5)神經解剖學雜志;(6)解剖學研究;(7)蘭州大學學報-醫學版。
審稿人:(1) Frontiers in Neuroanatomy; (2) PLOS ONE; (3) CNS Neuroscience & Therapeutics; (4) Toxicology; (5) Clinical and Experimental Pharmacology and Physiology; (6) Journal of Hazardous Materials; (7) Iranian Red Crescent Medical Journal; (8) Neural Regeneration Research; (9) Acta Pharmacologica Sinica.
1978-1983 蘭州醫學院臨床醫學系,獲學士學位;
1983-1989 蘭州醫學院人體解剖教研室,助教;
1985-1988 蘭州醫學院解剖教研室研究生,碩士研究生,獲碩士學位;
1989-1991 蘭州醫學院解剖教研室,講師;
1992-1993 法國里昂第一大學科學院,留學,導師:Dr. L. ASTIC;
1993-1995 法國里昂第一大學醫學院,博士后,導師: Prof. M. Jouvet and Dr. JS. Lin;
1995-1998 蘭州醫學院副教授;
1999-2000 加拿大蒙特利爾McGill大學,訪問學者。 導師: Prof. B E. Jones;
1999-2004 蘭州醫學院教授;
2005- 蘭州大學基礎醫學院神經科學研究所、教授(所長);人體解剖與組織胚胎研究所,教授。
1. Shao YF, Zhao P, Dong CY, Li J, Kong XP, Wang HL, Dai LR, Hou YP*. Neuropeptide S facilitates mice olfactory function through activation of cognate receptor-expressing neurons in the olfactory cortex. PLoS One 2013; 8(4):e62089. (IF=4.29)
2. Shao YF, Zhang Y, Zhao P, Yan WJ, Kong XP, Fan LL, Hou YP*. Botulinum toxin type A therapy in migraine: preclinical and clinical trials. Iran Red Crescent Med J 2013; e7704 (IF=0.371)
3. Jing YH, Hou YP, Song YF, Yin J. Methylprednisolone improves the survival of new neurons following transient cerebral ischemia in rats. Acta Neurobiol Exp (Wars). 2012; 72(3):240-52. (IF=2.11)
4. Qu WM, Yue XF, Sun Y, Fan K, Chen CR, Hou YP, Urade Y, Huang ZL. Honokiol promotes non-rapid eye movement sleep via the benzodiazepine site of the GABAA receptor in mice. Br J Pharmacol 2012; 167(3):587-593. (IF= 5.067)
5. Zhao P, Shao YF, Zhang M, Fan K, Kong XP, Wang R, Hou YP*. Neuropeptide S promotes wakefulness through activation of the posterior hypothalamic histaminergic and orexinergic neurons. Neuroscience 2012; 207:218-226. (IF=3.458)
6. Hou YP, Gu JY, Shao YF, Song YF, Jing YH, Wu WS, Pu S. The characteristics of placental transfer and tissue concentrations of nickel in late gestational rats and fetuses. Placenta 2011; 32:277-282. (IF=3.693)
7. Wang XW, Gu JY, Li Z, Song YF, Wu WS, Hou YP*. Gestational age and dose influence on placental transfer of 63Ni in rats. Placenta 2010; 31:305-311. (IF=3.693)
8. Li Z, Gu JY, Wang XW, Fan QH, Ge YX, Jiao ZX, Hou YP, Wu WS. Effects of cadmium on absorption, excretion, and distribution of nickel in rats. Biol Trace Elem Res 2010; 135(1-3):211-219. (IF= 1.923)
9. Zhang X, Sun YN, Xie P, Yang XG, Hou YP* Effect of microinjecting GABAA-receptor antagonist into the tuberomammillary nucleus on the sleep-wakefulness cycle after lesion of the ventrolateral preoptic area in rats. Neural Regen Res 2009; 4(1):53-57. (IF=0.216)
10. Zhu CM, Yao XR, Zhang WS, Song YF, Hou YP*. Progressive paradoxical sleep deprivation impairs partial memory and influences motor behavior following learning tasks in rats. Neural Regen Res 2008; 3(6):598-603. (IF=0.216)
11. Wen WD, Yuan F, Wang JL, Hou YP*. Botulinum toxin therapy in the ovalbumin-sensitized rat. Neuroimmunomodulation 2007; 14(2):78-83. (IF2010=2.642)
12. Hou YP, Zhang YP, Song YF, Zhu CM, Wang YC, Xie GL. Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo. Can J Physiol Pharmacol 2007; 85(2): 209-214. (IF=1.849)
13. Manns ID, Lee MG, Hou YP, Jones BE. Alpha 2 adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons. Euro J Neurosci 2003; 18:723-727. (IF=3.658)
14. Hou YP, Manns ID, Jones BE. Immunostaining of choliergic pontomesencephallic neurons for α1 versus α2 adrenergic receptors suggests different sleep-wake state activities and roles. Neuroscience 2002; 114 (3):517-521. (IF=3.458)
15. Lin JS, Gervasoni D, Hou Y, Vanni-Mercier G, Rambert F, Frydam A, Jouvet M. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. J Sleep Res 2000; 9:89-96. (IF=3.361)
16. Hou YP, Lin JS. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats. Acta Pharmacol Sin 1999; 20(9):813-818. (IF=2.354)
17. Hou YP, Song YF. The distribution of type B monoamine oxidase immunereactivity inhibited by i-methyl-4-penyl-1,2,3,6-tetrahydropyridine in the cat. Neurosci Bult (Chin. J. Neurosci) (1999), 15(4):279-284 (IF=1.311)
18. Lin JS, Hou Y, Rambert FA, Jouvet M. A wakening profiles of modafinil in sleep-deprived cats and its induction of brain c-fos expression pattern distinct from that caused by amphetamine or methylphenidate. Sleep Research 1997; 26:23-26
19. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996; 93:14128-14133. (IF=9.771)
20. Lin JS, Hou Y, Sakai K, Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neuroscience 1996; 16(4): 1523-1537. (IF=7.271)
21. Lin JS, Hou Y, Kitahama K, Jouvet M. Selective suppression of type B monoamine oxidase immunoreactivity in the raphe nuclei following MPTP administration in the cat, NeuroReport 1995; 6:321-324. (IF=1.822)
22. Hou Y, Giannetti N. Calcitoningene-related peptide immunoreactivity in the rat peripheral olfactory system during post-natal development. Chem Senses 1994; 16:88. (IF=2.327)
九、學術團隊(研究生)